Renee A. Schoon

3.9k total citations · 1 hit paper
41 papers, 3.1k citations indexed

About

Renee A. Schoon is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Renee A. Schoon has authored 41 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Immunology, 9 papers in Molecular Biology and 9 papers in Oncology. Recurrent topics in Renee A. Schoon's work include Immune Cell Function and Interaction (30 papers), T-cell and B-cell Immunology (19 papers) and Calcium signaling and nucleotide metabolism (6 papers). Renee A. Schoon is often cited by papers focused on Immune Cell Function and Interaction (30 papers), T-cell and B-cell Immunology (19 papers) and Calcium signaling and nucleotide metabolism (6 papers). Renee A. Schoon collaborates with scholars based in United States, Brazil and Czechia. Renee A. Schoon's co-authors include Paul J. Leibson, Daniel D. Billadeau, Christopher J. Dick, Jadee L. Upshaw, Robert T. Abraham, Laura N. Arneson, Larry M. Karnitz, Claudia C.S. Chini, Joel M. Reid and Eduardo N. Chini and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and The Journal of Experimental Medicine.

In The Last Decade

Renee A. Schoon

40 papers receiving 3.1k citations

Hit Papers

CD38 Dictates Age-Related NAD Decline and Mitochondrial D... 2016 2026 2019 2022 2016 200 400 600

Peers

Renee A. Schoon
Renee A. Schoon
Citations per year, relative to Renee A. Schoon Renee A. Schoon (= 1×) peers Juliane Lüscher‐Firzlaff

Countries citing papers authored by Renee A. Schoon

Since Specialization
Citations

This map shows the geographic impact of Renee A. Schoon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Renee A. Schoon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Renee A. Schoon more than expected).

Fields of papers citing papers by Renee A. Schoon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Renee A. Schoon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Renee A. Schoon. The network helps show where Renee A. Schoon may publish in the future.

Co-authorship network of co-authors of Renee A. Schoon

This figure shows the co-authorship network connecting the top 25 collaborators of Renee A. Schoon. A scholar is included among the top collaborators of Renee A. Schoon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Renee A. Schoon. Renee A. Schoon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Costello, Brian A., Jun Yin, Renee M. McGovern, et al.. (2020). Abstract CT114: Pharmacokinetic analysis of navitoclax in combination with sorafenib in patients with relapsed or refractory solid organ tumors. Cancer Research. 80(16_Supplement). CT114–CT114. 1 indexed citations
3.
Camacho-Pereira, Juliana, Mariana G. Tarragó, Claudia C.S. Chini, et al.. (2016). CD38 Dictates Age-Related NAD Decline and Mitochondrial Dysfunction through an SIRT3-Dependent Mechanism. Cell Metabolism. 23(6). 1127–1139. 616 indexed citations breakdown →
4.
Neff, Jadee, Christopher J. Dick, Renee A. Schoon, et al.. (2011). 2B4 utilizes ITAM-containing receptor complexes to initiate intracellular signaling and cytolysis. Molecular Immunology. 48(9-10). 1149–1159. 15 indexed citations
5.
Oppegard, Lisa M., Andrei V. Ougolkov, Renee A. Schoon, et al.. (2008). Novel acridine-based compounds that exhibit an anti-pancreatic cancer activity are catalytic inhibitors of human topoisomerase II. European Journal of Pharmacology. 602(2-3). 223–229. 64 indexed citations
6.
Arneson, Laura N., et al.. (2007). Differential Regulation of Human NK Cell-Mediated Cytotoxicity by the Tyrosine Kinase Itk. The Journal of Immunology. 178(6). 3575–3582. 72 indexed citations
7.
Arneson, Laura N., Adipong Brickshawana, Colin M. Segovis, et al.. (2007). Cutting Edge: Syntaxin 11 Regulates Lymphocyte-Mediated Secretion and Cytotoxicity. The Journal of Immunology. 179(6). 3397–3401. 70 indexed citations
8.
Upshaw, Jadee L., Laura N. Arneson, Renee A. Schoon, et al.. (2006). NKG2D-mediated signaling requires a DAP10-bound Grb2-Vav1 intermediate and phosphatidylinositol-3-kinase in human natural killer cells. Nature Immunology. 7(5). 524–532. 225 indexed citations
9.
Billadeau, Daniel D., Jadee L. Upshaw, Renee A. Schoon, Christopher J. Dick, & Paul J. Leibson. (2003). NKG2D-DAP10 triggers human NK cell–mediated killing via a Syk-independent regulatory pathway. Nature Immunology. 4(6). 557–564. 298 indexed citations
10.
Lou, Zhenkun, Daniel D. Billadeau, Doris N. Savoy, Renee A. Schoon, & Paul J. Leibson. (2001). A Role for a RhoA/ROCK/LIM-Kinase Pathway in the Regulation of Cytotoxic Lymphocytes. The Journal of Immunology. 167(10). 5749–5757. 44 indexed citations
11.
Chini, Claudia C.S., Markus D. Boos, Christopher J. Dick, Renee A. Schoon, & Paul J. Leibson. (2000). Regulation of p38 mitogen-activated protein kinase during NK cell activation. European Journal of Immunology. 30(10). 2791–2798. 38 indexed citations
12.
Brumbaugh, Kathryn M., Bryce A. Binstadt, Daniel D. Billadeau, et al.. (1997). Functional Role for Syk Tyrosine Kinase in Natural Killer Cell–mediated Natural Cytotoxicity. PubMed Central.
13.
Brumbaugh, Kathryn M., Juan J. Pérez‐Villar, Christopher J. Dick, et al.. (1996). Clonotypic differences in signaling from CD94 (kp43) on NK cells lead to divergent cellular responses. The Journal of Immunology. 157(7). 2804–2812. 53 indexed citations
14.
Ting, Adrian T., Christopher J. Dick, Renee A. Schoon, et al.. (1995). Interaction between lck and syk Family Tyrosine Kinases in Fcγ Receptor-initiated Activation of Natural Killer Cells. Journal of Biological Chemistry. 270(27). 16415–16421. 89 indexed citations
15.
Karnitz, Larry M., et al.. (1995). Fc Receptor Stimulation of PI 3‐Kinase in NK Cells Is Associated with Protein Kinase C–independent Granule Release and Cell‐mediated Cytotoxicity. Annals of the New York Academy of Sciences. 766(1). 209–213. 2 indexed citations
16.
Karnitz, Larry M., et al.. (1994). Fc receptor stimulation of phosphatidylinositol 3-kinase in natural killer cells is associated with protein kinase C-independent granule release and cell-mediated cytotoxicity.. The Journal of Experimental Medicine. 180(4). 1427–1435. 129 indexed citations
17.
Ting, Adrian T., et al.. (1994). Cytokine-enhanced NK cell-mediated cytotoxicity. Positive modulatory effects of IL-2 and IL-12 on stimulus-dependent granule exocytosis.. The Journal of Immunology. 152(5). 2098–2104. 63 indexed citations
18.
Ting, Adrian T., Larry M. Karnitz, Renee A. Schoon, Robert T. Abraham, & Paul J. Leibson. (1992). Fc gamma receptor activation induces the tyrosine phosphorylation of both phospholipase C (PLC)-gamma 1 and PLC-gamma 2 in natural killer cells.. The Journal of Experimental Medicine. 176(6). 1751–1755. 120 indexed citations
19.
Voss, Lesley, et al.. (1991). Defective T-lymphocyte signal transduction and function in leukocyte adhesion deficiency. Journal of Clinical Immunology. 11(4). 175–183. 7 indexed citations
20.
Paya, C. V., et al.. (1988). Tumor necrosis factor and lymphotoxin secretion by human natural killer cells leads to antiviral cytotoxicity.. The Journal of Immunology. 141(6). 1989–1995. 55 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026